@newsarea.bsky.social·Jul 18, 2026

Cholesterol Drug Cuts Alzheimer’s Biomarker in Most At-Risk Gene Carriers Obicetrapib, a cholesterol-lowering drug already in Phase 3 cardiovascular trials, significantly reduced a validated Alzheimer's blood biomarker in APOE4 gene carriers at AAIC 2026 in London — with the effect more than…